While these studies focused on prostate cancer, we have also previously shown that the ability of SSL-IPA-3 to decrease cell growth was dependent on the expression of PAK-1 in a diverse set of breast cancer cells. This evidence concerns the gene PAK1 and prostate carcinoma.